Natera, Inc. SEC filings NTRA

Natera, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Jul 11, 2022. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (results of operations). The company's fiscal year ends on December 31.

Natera, Inc. SEC filings
Form Description Filed Period
S-8 Employee stock plan registration Aug 7, 2026 —
S-8 Employee stock plan registration Mar 2, 2026 —
S-3ASR Automatic shelf registration Dec 10, 2025 —
S-8 Employee stock plan registration Dec 5, 2025 —
S-3 Shelf registration Dec 5, 2025 —
S-8 Employee stock plan registration Oct 21, 2025 —
S-8 Employee stock plan registration Feb 28, 2025 —
S-8 Employee stock plan registration Jul 16, 2024 —
S-8 Employee stock plan registration Mar 1, 2024 —
424B5 Prospectus supplement Sep 7, 2023 —
S-3ASR Automatic shelf registration Sep 6, 2023 —
S-8 Employee stock plan registration Mar 1, 2023 —
424B5 Prospectus supplement Nov 16, 2022 —
S-3ASR Automatic shelf registration Nov 15, 2022 —

Showing 14 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Medical Laboratories (SIC 8071)
Listed as
NTRA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Austin, TX
SEC filer status
Large accelerated filer
SEC CIK
1604821
Former names
Natera, Inc. (until Nov 5, 2026)

Other Services-Medical Laboratories companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.